logo
Select company
Select metric
$ -3.64EBIT per Share
VS
Market
8
Sector
19
Industry
23
History
9
$ 14.3Close
$ 8.73 - $ 21.81 52-Week Range
Ticker Information

Ticker

SNDX

Company Name

SYNDAX PHARMACEUTICALS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

SYNDAX PHARMACEUTICALS INC - EBIT per Share Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

SNDX - EBITPS Historical data
DateEarning Before Interest & Taxes (EBIT)EBIT per ShareShare FactorWeighted Average Shares
6/30/2025$ -314.25M$ -3.64186.34M
3/31/2025$ -318.28M$ -3.69186.17M
12/31/2024$ -313.83M$ -3.67185.62M
9/30/2024$ -296.88M$ -3.47185.43M
6/30/2024$ -263.85M$ -3.09185.27M
3/31/2024$ -240.41M$ -2.82185.21M
12/31/2023$ -209.15M$ -2.97170.37M
9/30/2023$ -175.89M$ -2.52169.86M
6/30/2023$ -158.47M$ -2.28169.64M
3/31/2023$ -150.77M$ -2.17169.44M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • SYNDAX PHARMACEUTICALS INC's latest trailing twelve months (TTM) EBITPS stands at $ -1.57.
  • Over the past 5 years, SYNDAX PHARMACEUTICALS INC's average EBITPS has been $ -2.02.
  • The median EBITPS for SYNDAX PHARMACEUTICALS INC during this period was $ -2.22
  • SYNDAX PHARMACEUTICALS INC reached its highest EBITPS over the past 5 years at $ 0.52.
  • The lowest EBITPS recorded by SYNDAX PHARMACEUTICALS INC in the same timeframe $ -3.69

SYNDAX PHARMACEUTICALS INC's EBITPS vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBITPS Benchmarks
CompanyEBITPS
NRIX : NURIX THERAPEUTICS INC $ -2.9URGN : UROGEN PHARMA LTD $ -2.85TBPH : THERAVANCE BIOPHARMA INC $ 0.85ZVRA : ZEVRA THERAPEUTICS INC $ 0.55KURA : KURA ONCOLOGY INC $ -2.21SAGE : SAGE THERAPEUTICS INC $ -4.81GYRE : GYRE THERAPEUTICS INC $ 0.08NKTR : NEKTAR THERAPEUTICS $ -6.82EYPT : EYEPOINT PHARMACEUTICALS INC $ -2.51ZYME : ZYMEWORKS INC $ -0.89

Similar metrics to Shares WA:

Definition of EBIT per Share

[Calculation] The amount of earnings before interest and taxes attributed to each share, calculated as [EBIT] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
EBIT / (Shares WA * Share Factor)
(=) EBITPS EBITPS for SYNDAX PHARMACEUTICALS INC is calculated as follows: EBIT [ $ -69.14M ] / (Shares WA [ 44.16M ] * Share Factor [ 1 ])
(=) EBITPS [ $ -1.57 ]

SNDX - EBIT per Share, Last 5 years

$ -3.69

Minimum

Mar 31, 2025

$ 0.52

Maximum

Dec 31, 2021

$ -2.02

Average

$ -2.22

Median

EBITPS Benchmark Analysis

 The chart above depicts the distribution of EBITPS for companies in the Total Stock Market. The average EBITPS of the companies is $ 1.16 with a standard deviation of $ 3.41.
The following table provides additional summary stats:
EBITPS in the Market:
filtered constituents3.79K
min$ -9.71
max$ 10.76
average$ 1.16
median$ 0.39
std$ 3.41